Australia markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6900+0.0400 (+1.10%)
At close: 04:00PM EDT
3.9000 +0.21 (+5.69%)
Pre-market: 08:01AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Assets
Current assets
Cash
Cash and cash equivalents
151,024
149,158
152,108
29,249
Total cash
151,024
149,158
152,108
29,249
Other current assets
653
354
371.914
-
Total current assets
154,386
152,705
161,616
34,542
Non-current assets
Total non-current assets
0
0
0
0
Total assets
154,386
152,705
161,616
34,542
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
4,322
3,825
4,740
3,989
Accrued liabilities
5,935
4,647
4,413
2,749
Deferred revenues
917
444
443.831
0
Total current liabilities
12,534
10,214
10,798
7,306
Non-current liabilities
Total non-current liabilities
0
0
0
0
Total liabilities
12,534
10,214
10,798
7,306
Stockholders' equity
Common stock
82
78
75.92
62.047
Retained earnings
-293,069
-245,564
-197,586
-159,677
Total stockholders' equity
141,852
142,491
150,818
27,237
Total liabilities and stockholders' equity
154,386
152,705
161,616
34,542